ALKBH5 and Miyoshi myopathy: Cell viability assays (Figure 6B), VEGF ELISA assays (Figure 6D), cell apoptosis assays (Figure 6F) and cell migration/invasion assays (Figure 6G&H) and showed that SAV1-silencing in ALKBH5 overexpressing MM cells significantly attenuated the ALKBH5-mediated promotion of MM progression.